1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Baseline and clinical data in patients with and without progression—univariate analysis
Patient Characteristics Total (n = 28) Progressed (n = 13) Stable (n = 15) P Value Age (mean) (SD) (yr) 50.4 (16.6) 49.1 (19.0) 51.6 (14.8) .70 Sex, male/female 14:14 7:6 7:8 .56 Initial tumor size (mean) (SD) (mL) 30.7 (33.8) 32.3 (26.3) 29.4 (40.1) .82 Tumor type, oligo/astro 19/9 9/4 10/5 .80 Follow-up time (mean) (range) (mo) 40.9 (12–109) 42.8 (12–89) 39.3 (12–109) .75 No. of MRIs/patient (mean) (SD) 8.8 (4.3) 9.8 (5.0) 7.9 (3.6) .26 Extent of initial tumor resection (No.) (>50% of initial volume) 15 (53.5%) 8 (61.5%) 7 (46.6%) .68
Note:—oligo indicates oligodendroglioma; astro, astrocytoma.